对肺状细胞癌和肺腺癌的新辅助疗法的有效性:一项回顾性比较研究
Yi Gan1, Zhihao Liu1, Zhiwei Tang1
1Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China.
Oncology letters
|November 29, 2023
概括
手术前的新辅助疗法在非小细胞肺癌 (NSCLC) 中显示出前景. 化学疗法与免疫疗法相结合,改善了病理反应,特别是在肺状细胞癌 (LUSC) 患者中.
科学领域:
- 在瘤学瘤学.
- 胸部外科手术 胸部外科手术
- 癌症研究 癌症研究
背景情况:
- 新辅助疗法是一种标准的癌症治疗方法.
- 它在非小细胞肺癌 (NSCLC) 亚型中的有效性尚不清楚.
- 了解特定亚型的反应对于个性化治疗至关重要.
研究的目的:
- 在两个主要的NSCLC亚型中比较术前新辅助疗法的临床疗效.
- 为了评估新辅助化疗与免疫治疗结合的影响.
- 确定肺平细胞癌 (LUSC) 和肺腺癌 (LUAD) 之间的病理反应的潜在差异.
主要方法:
- 对接受新辅助治疗的NSCLC患者的回顾性分析 (2016年1月 - 2022年8月).
- 基于组织学 (LUSC与LUAD) 和治疗策略的分层.
- 临床,临床病理学,成像学和病理反应数据的比较.
主要成果:
- 分析了36个LUSC和31个LUAD病例.
- 新辅助化疗加免疫疗法在LUSC与LUAD (P=0.06) 中显示出更高的病理反应率.
- 与单独化疗相比,LUSC中新辅助化疗加免疫治疗的病理完整响应率明显高于单独化疗 (P=0.01).
结论:
- 术前化学疗法与免疫疗法相结合,可能会增强NSCLC患者的病理反应.
- 这种组合治疗似乎对LUSC特别有益.
- 这些发现为优化NSCLC的新辅助治疗策略提供了新的见解.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.1K
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...